Compare ENSC & REED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENSC | REED |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 8.8M |
| IPO Year | 2017 | 2009 |
| Metric | ENSC | REED |
|---|---|---|
| Price | $0.39 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $5.13 | N/A |
| AVG Volume (30 Days) | 535.6K | ★ 2.6M |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.24 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,066,650.00 | ★ $34,065,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $0.33 |
| 52 Week High | $2.17 | $5.97 |
| Indicator | ENSC | REED |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 56.68 |
| Support Level | $0.39 | $0.72 |
| Resistance Level | $0.44 | $1.04 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 2.44 | 54.32 |
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.